AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Trading Down 2.2% – What’s Next?

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTALGet Free Report) fell 2.2% during mid-day trading on Tuesday . The company traded as low as $11.84 and last traded at $11.84. Approximately 781,410 shares changed hands during mid-day trading, a decline of 6% from the average session volume of 833,046 shares. The stock had previously closed at $12.11.

AGF U.S. Market Neutral Anti-Beta Fund Price Performance

The company has a market capitalization of $296.59 million, a P/E ratio of 17.67 and a beta of -0.63. The company has a fifty day moving average price of $11.67 and a 200 day moving average price of $12.96.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in BTAL. J.Safra Asset Management Corp raised its stake in AGF U.S. Market Neutral Anti-Beta Fund by 10.0% during the 4th quarter. J.Safra Asset Management Corp now owns 8,142 shares of the company’s stock valued at $117,000 after acquiring an additional 741 shares in the last quarter. IFP Advisors Inc grew its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 7.4% in the third quarter. IFP Advisors Inc now owns 22,864 shares of the company’s stock worth $364,000 after purchasing an additional 1,582 shares in the last quarter. CoreCap Advisors LLC acquired a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund during the second quarter valued at $36,000. Triumph Capital Management acquired a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund during the third quarter valued at $70,000. Finally, Worth Asset Management LLC increased its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 20.5% during the first quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock valued at $425,000 after purchasing an additional 5,190 shares during the period.

About AGF U.S. Market Neutral Anti-Beta Fund

(Get Free Report)

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.

See Also

Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.